MedTrace Logo

Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation

NCT01741064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257

Last updated 2012-12-04

No results posted yet for this study

Summary

The purpose of the study is to evaluate the long term vascular morbidity and mortality in kidney transplant recipients based on one year post transplant levels of intact parathyroid hormone.

Conditions

  • Secondary Hyperparathyroidism
  • Disorder Related to Renal Transplantation

Sponsors & Collaborators

  • Karolinska University Hospital

    collaborator OTHER

  • Skane University Hospital

    lead OTHER

Principal Investigators

  • Gunnar Sterner, MD A/Prof · Dept of Nephrology and Transplantation Skane University Hospital Malmo

  • Astrid Seeberger, PhD, A/Prof · ´Dept of nephrology, Karolinska University Hospital Huddinge, Stockholm

  • Elin Isaksson, MD · Dept of Nephrology and Transplantation Skane University Hosptial Malmö

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-10-31
Completion
2012-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741064 on ClinicalTrials.gov